NCT03812861 (CAMDS) is a NA clinical trial of CAMDS bundle in Surgery--Complications, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Who is sponsoring NCT03812861?

NCT03812861 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

What drugs are being tested in NCT03812861?

Interventions in NCT03812861: CAMDS bundle.

What condition does NCT03812861 study?

NCT03812861 studies Surgery--Complications.

Is NCT03812861 still recruiting?

NCT03812861 is currently completed. Last updated 23 January 2019.

Last reviewed 2019-01-23 · How we verify

NCT03812861: CAMDS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cognitive Aids for the Management of Deteriorating Surgical Patients

Completed NA Last updated 23 January 2019

What this trial tests

NA trial testing CAMDS bundle in Surgery--Complications in 50 participants. Completed in 18 December 2018.

Timeline

7 February 2017

Primary endpoint
18 December 2018

18 December 2018

Quick facts

Lead sponsor	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	7 February 2017
Primary completion	18 December 2018
Estimated completion	18 December 2018
Sites	1 location across Netherlands

Drugs / interventions tested

CAMDS bundle

Conditions studied

Surgery--Complications — all drugs for Surgery--Complications →

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) — full company profile →

Who can join

Eligibility, any sex, with Surgery--Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background and Goal of Study: Adherence to best practice management of emergencies improves through the use of cognitive aids. Aim of this study was to develop and validate cognitive aids for management of deteriorating surgical ward patients (CAMDS) in order to improve adherence to best practice and hereby reduce the likelihood of failure to rescue. Materials and Methods: Fifty surgical teams will be randomly assigned to manage 150 standardised high fidelity simulation cases of deteriorating patients using the CAMDS or not. There are 10 standardised patient scenarios; pneumonia, pneumothorax, bradycardia, cardiac arrest shockable and non-shockable rhythm, bleeding, myocardial infarction, anaphylaxis, sepsis and loss of consciousness. Two independent observers will score the team's performance in adhering to all the management steps. To assess perceived usability of the CAMDS participants will be asked about eight aspects of the CAMDS. These items will be scored on a Likert scale (0= strongly disagree to 4= strongly agree).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of Cognitive Aids on Adherence to Best Practice in the Treatment of Deteriorating Surgical Patients: A Randomized Clinical Trial in a Simulation Setting.
Koers L, van Haperen M, Meijer CGF, van Wandelen SBE, et al · · 2020 · cited 22× · PMID 31774483 · DOI 10.1001/jamasurg.2019.4704

Verify or expand the search:

Other recruiting trials for Surgery--Complications

Currently open trials in the same condition.

NCT05219058 — Reconstruction in Extended MArgin Cancer Surgery · recruiting
NCT04967391 — Tumescence in HNC Skin Graft Reconstruction · Phase 3 · active not recruiting
NCT03561376 — Zinc Oxide Versus Petrolatum Following Skin Surgery · EARLY_PHASE1 · recruiting
NCT05155878 — Prognostic Factors in Periampullary Tumors and Cysts · recruiting
NCT04824066 — The Role of Wearable Devices in Cardiothoracic Surgery: Predicting and Detecting Early Postoperative Complications · recruiting

Other Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trials

Trials by the same sponsor.

NCT07301021 — Velopharyngeal Insufficiency After Maxillomandibular Advancement Osteotomy in Obstructive Sleep Apnea Patients · not yet recruiting
NCT07359482 — sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 · Phase 3 · not yet recruiting
NCT07457957 — Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents · NA · not yet recruiting
NCT06909045 — Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease · NA · recruiting
NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03812861 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Last refreshed: 23 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03812861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing